Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Emerson proposal to acquire AspenTech at $15.3 billion enterprise valuation
We are advising Emerson on its proposal to acquire the remaining outstanding shares of AspenTech
ATSG $3.1 billion acquisition by Stonepeak
We are advising Air Transport Services Group on its going-private transaction
Elevance Health $5.2 billion senior notes offering
The investment-grade notes are due 2026, 2030, 2031, 2035, 2055 and 2064
MicroStrategy $21 billion at-the-market offering
The ATM program is the largest in history
Boeing $24.25 billion common and depositary share offerings
The combined offering is the largest U.S. follow-on offering in history
Molecular Partners $20 million follow-on offering
The ADSs are listed on the Nasdaq Global Select Market
Silver Spike Investment Corp. loan portfolio acquisition
We advised Silver Spike Investment Corp., now named Chicago Atlantic BDC, Inc., on the transaction
Horizon Robotics HK$5.41 billion IPO
We advised Horizon Robotics on its IPO and HKEX listing
Bold Eagle Acquisition $250 million IPO
The units are listed on the Nasdaq Global Market
PL Developments exchange offer and consent solicitation
The exchange offer included the issuance of new PIK toggle senior secured notes due 2029